Which class of chemotherapy agents works by binding directly to DNA to inhibit DNA synthesis?

Which class of chemotherapy agents works by binding directly to DNA to inhibit DNA synthesis?

• A. Antitumor antibiotics
• B. Antimetabolites
• C. Alkylating agents
• D. Hormonal therapies

Answer: (A)

The concept being tested is how some chemotherapy drugs act by directly engaging DNA to block its replication. Antitumor antibiotics are known for binding to DNA itself, which disrupts the DNA's ability to be copied and read during replication and transcription. Drugs like doxorubicin intercalate into DNA and inhibit topoisomerase II, preventing proper DNA unwinding and causing replication arrest. Bleomycin binds DNA and induces breaks, further halting synthesis. This direct DNA interaction is what makes this class fit the description. In contrast, antimetabolites work by mimicking normal nucleotides and interfering with enzymes involved in DNA synthesis, not by binding DNA itself. Alkylating agents bind to DNA and create cross-links or breaks through covalent attachment, but their primary action is cross-linking DNA rather than the direct binding and intercalation described in the statement. Hormonal therapies act on hormone receptors or synthesis pathways rather than on DNA binding.

The concept being tested is how some chemotherapy drugs act by directly engaging DNA to block its replication. Antitumor antibiotics are known for binding to DNA itself, which disrupts the DNA's ability to be copied and read during replication and transcription. Drugs like doxorubicin intercalate into DNA and inhibit topoisomerase II, preventing proper DNA unwinding and causing replication arrest. Bleomycin binds DNA and induces breaks, further halting synthesis. This direct DNA interaction is what makes this class fit the description.

In contrast, antimetabolites work by mimicking normal nucleotides and interfering with enzymes involved in DNA synthesis, not by binding DNA itself. Alkylating agents bind to DNA and create cross-links or breaks through covalent attachment, but their primary action is cross-linking DNA rather than the direct binding and intercalation described in the statement. Hormonal therapies act on hormone receptors or synthesis pathways rather than on DNA binding.